Internal Medicine, Gastroenterology · Columbus, OH
NPI
1558315382
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
700 E Broad St, 2nd Floor
Columbus, OH, 43215
Phone (614) 458-1183
Groups this clinician bills Medicare through
Medicare paid, 2024
$91K
1,125 services
Medicare patients, 2024
445
Average age 73
Drug cost, 2024
$565K
2,482 prescriptions
Company payments, 2025
$58K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tasos Manokas was code G0500 (moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito), 225 times for 208 patients. In total Tasos Manokas billed 1,125 services in 47 codes, and Medicare paid $91K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-12.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 225 | 208 | $4.32 | $972 |
| 43239 Upper GI Endoscopy | Facility | 139 | 135 | $83.52 | $12K |
| 45385 Colonoscopy - Lesion Removal | Facility | 115 | 115 | $196.32 | $23K |
| 99233 Hospital E&M - Subsequent | Facility | 94 | 57 | $87.83 | $8,256 |
| 99153 Anesthesia | Facility | 86 | 86 | $8.54 | $735 |
| 99223 Hospital E&M - Initial | Facility | 81 | 81 | $128.22 | $10K |
| 99214 Office E&M - Established | Office | 64 | 50 | $91.15 | $5,834 |
| 45380 Lower GI Endoscopy - Other | Facility | 43 | 43 | $104.54 | $4,495 |
| 99213 Office E&M - Established | Office | 38 | 34 | $57.81 | $2,197 |
| 43235 Upper GI Endoscopy | Facility | 36 | 33 | $85.70 | $3,085 |
| 43450 Digestive/Gastrointestinal | Facility | 28 | 25 | $29.88 | $837 |
| 43251 Upper GI Endoscopy | Facility | 27 | 26 | $129.99 | $3,510 |
| 45378 Lower GI Endoscopy - Other | Facility | 21 | 20 | $113.97 | $2,393 |
| 99202 Office E&M - New | Facility | 20 | 20 | $35.79 | $716 |
By year: 2022 $95K for 1,130 services; 2023 $92K for 1,093 services; 2024 $91K for 1,125 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tasos Manokas prescribed most often to Medicare patients was Pantoprazole Sodium, with 699 prescriptions and refills. In total Tasos Manokas wrote 2,482 Medicare prescriptions that cost $565K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 699 | 1,805 | 234 | $8,523 |
| Famotidine Generic | 226 | 521 | 68 | $2,125 |
| Sucralfate Generic | 160 | 235 | 72 | $5,020 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 146 | 146 | 145 | $9,644 |
| Ondansetron Odt Ondansetron | 99 | 99 | 23 | $2,004 |
| Metoclopramide Hcl Generic | 95 | 125 | 35 | $1,393 |
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 91 | 91 | 90 | $1,705 |
| Lansoprazole Generic | 90 | 214 | 29 | $2,154 |
| Dicyclomine Hcl Generic | 66 | 76 | 20 | $616 |
| Linzess Linaclotide | 62 | 102 | 22 | $53K |
| Trulance Plecanatide | 55 | 55 | Under 11 | $30K |
| Hydrocortisone Generic | 51 | 51 | 28 | $1,037 |
| Dexlansoprazole Dr Dexlansoprazole | 49 | 99 | Under 11 | $13K |
| Alosetron Hcl Generic | 49 | 63 | Under 11 | $46K |
| Omeprazole Generic | 43 | 127 | 16 | $576 |
Brand drugs: - claims; generic drugs: 2,145 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tasos Manokas $58K ($58K in general payments such as food, travel and fees) from 21 companies. The largest payer was Abbvie Inc. with $28K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 76 | $28K |
| Genzyme Corporation SNY | 15 | $19K |
| Phathom Pharmaceuticals, Inc. PHAT | 14 | $3,895 |
| Janssen Biotech, Inc. JNJ | 20 | $2,184 |
| Regeneron Healthcare Solutions, Inc. REGN | 7 | $2,085 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 29 | $431 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 19 | $357 |
| QOL Medical, LLC | 6 | $306 |
| Madrigal Pharmaceuticals MDGL | 6 | $213 |
| Gilead Sciences, Inc. GILD | 10 | $199 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.